|
|
Suppliers for
Esmolol hydrochloride
|
Properties | CAS |
81161-17-3 | Formula |
C16H25NO4.HCl |
|
|
14 Registered suppliers
Molecular Formula: C16H25NO4.HCl;C16H26ClNO4 Molecular Weight: 331,15
More details are to be found here
Appearance | white powder
| Purity | 99% min
| melting point | 48-50°C
| solubility | H2O=> soluble12mg/mL
| It is an aryloxypropylamine class of ultra-short-acting selective β 1 receptor blocker, which mainly inhibits β 1 receptors by competing for catecholamine binding sites. It has the effects of slowing down resting and exercise heart rate, lowering blood pressure and myocardial oxygen consumption. |
Appearance | white powder
| Purity | 99% min
| melting point | 48-50°C
| solubility | H2O=> soluble12mg/mL
| It is an aryloxypropylamine class of ultra-short-acting selective β 1 receptor blocker, which mainly inhibits β 1 receptors by competing for catecholamine binding sites. It has the effects of slowing down resting and exercise heart rate, lowering blood pressure and myocardial oxygen consumption. |
Appearance | white powder
| Purity | 99% min
| melting point | 48-50°C
| solubility | H2O=> soluble12mg/mL
| It is an aryloxypropylamine class of ultra-short-acting selective β 1 receptor blocker, which mainly inhibits β 1 receptors by competing for catecholamine binding sites. It has the effects of slowing down resting and exercise heart rate, lowering blood pressure and myocardial oxygen consumption. |
Appearance | white powder
| Purity | 99% min
| melting point | 48-50°C
| solubility | H2O=> soluble12mg/mL
| It is an aryloxypropylamine class of ultra-short-acting selective β 1 receptor blocker, which mainly inhibits β 1 receptors by competing for catecholamine binding sites. It has the effects of slowing down resting and exercise heart rate, lowering blood pressure and myocardial oxygen consumption. |
Appearance | white powder
| Purity | 99% min
| melting point | 48-50°C
| solubility | H2O=> soluble12mg/mL
| It is an aryloxypropylamine class of ultra-short-acting selective β 1 receptor blocker, which mainly inhibits β 1 receptors by competing for catecholamine binding sites. It has the effects of slowing down resting and exercise heart rate, lowering blood pressure and myocardial oxygen consumption. |
Appearance | white powder
| Purity | 99% min
| melting point | 48-50°C
| solubility | H2O=> soluble12mg/mL
| It is an aryloxypropylamine class of ultra-short-acting selective β 1 receptor blocker, which mainly inhibits β 1 receptors by competing for catecholamine binding sites. It has the effects of slowing down resting and exercise heart rate, lowering blood pressure and myocardial oxygen consumption. |
Appearance | white powder
| Purity | 99% min
| melting point | 48-50°C
| solubility | H2O=> soluble12mg/mL
| It is an aryloxypropylamine class of ultra-short-acting selective β 1 receptor blocker, which mainly inhibits β 1 receptors by competing for catecholamine binding sites. It has the effects of slowing down resting and exercise heart rate, lowering blood pressure and myocardial oxygen consumption. |
Appearance | white powder
| Purity | 99% min
| melting point | 48-50°C
| solubility | H2O=> soluble12mg/mL
| It is an aryloxypropylamine class of ultra-short-acting selective β 1 receptor blocker, which mainly inhibits β 1 receptors by competing for catecholamine binding sites. It has the effects of slowing down resting and exercise heart rate, lowering blood pressure and myocardial oxygen consumption. |
Appearance | white powder
| Purity | 99% min
| melting point | 48-50°C
| solubility | H2O=> soluble12mg/mL
| It is an aryloxypropylamine class of ultra-short-acting selective β 1 receptor blocker, which mainly inhibits β 1 receptors by competing for catecholamine binding sites. It has the effects of slowing down resting and exercise heart rate, lowering blood pressure and myocardial oxygen consumption. |
|
|
|
Privileged suppliers
Last update 2024-04-30
|